Pharma Stocks
-
Rockwell Automation Pharma Win Highlights Digital Growth And Valuation Tension
Rockwell Automation (NYSE:ROK), together with Rovi and Adasoft, has rolled out a digital, paperless batch execution system for pharmaceutical production.…
Read More » -
Cardinal Health (CAH) Surged Following Improved Specialty Mix in Pharma
Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the…
Read More » -
Simulations Plus stock gains momentum amid AI-driven drug discovery boom
The Simulations Plus stock (ISIN: US82834F1012) is drawing investor attention as pharmaceutical companies accelerate AI integration in drug development pipelines.…
Read More » -
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
Pfizer issued a warning to it’s shareholders to not to participate in an unsolicited mini-tender offer from a company called…
Read More » -
Sanofi S.A. stock faces pressure amid China supply chain shifts in pharma sector peers
Sanofi S.A. (ISIN: FR0000127771) shares test key supports as semiconductor peers like STMicroelectronics advance China localization, raising questions for European…
Read More » -
Earnings due 24 Mar: NWRN.SW Newron Pharmaceuticals S.p.A. (SIX) pipeline test
The NWRN.SW stock trades intraday at CHF 15.40 as investors prepare for Newron Pharmaceuticals S.p.A.’s earnings on 24 Mar 2026.…
Read More » -
Mankind Pharma Ltd Falls to 52-Week Low of Rs 1929.55 as …
Price Action and Market Context The stock’s fall comes as the Pharmaceuticals & Biotechnology sector itself has declined by 3.09%…
Read More » -
Collegium Pharmaceutical (COLL) Valuation Check After Recent Share Price Volatility
Collegium Pharmaceutical overview Collegium Pharmaceutical (COLL) has drawn attention after recent trading showed a 2.4% daily decline and a 21%…
Read More » -
Alnylam Pharmaceuticals stock faces technical pressure amid mixed signals on Nasdaq
Alnylam Pharmaceuticals (ISIN: US02005N1000) shows conflicting technical indicators, with short-term moving averages signaling sell while longer-term trends point to buy.…
Read More » -
AstraZeneca plc stock faces pressure amid monthly declines but shows YTD strength in volatile pharma
AstraZeneca plc (ISIN: GB0009895292) shares have declined 9.88% over March 2026, ranking among monthly losers, yet boast 100.5% YTD gains.…
Read More »